S. Maltby

Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)

David A. Jolliffe, M. Talaei, F. Kee, 2021, BMC Medicine.

Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT)

David A. Jolliffe, J. Norrie, M. Talaei, 2022, BMJ.

Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK)

David A. Jolliffe, M. Talaei, F. Kee, 2022, Vaccines.

Vitamin D Supplements for Prevention of Covid-19 or other Acute Respiratory Infections: a Phase 3 Randomized Controlled Trial (CORONAVIT)

P. Pfeffer, C. Relton, S. Faustini, 2022, medRxiv.

Determinants of antibody responses to two doses of ChAdOx1 nCoV-19 or BNT162b2 and a subsequent booster dose of BNT162b2 or mRNA-1273: population-based cohort study (COVIDENCE UK)

David A. Jolliffe, M. Talaei, F. Kee, 2022, medRxiv.

Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)

David A. Jolliffe, M. Talaei, F. Kee, 2021, BMC Medicine.